A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease
Clinical trial NCT02956486 · TERMINATED
Trial details
- NCT number
- NCT02956486
- Sponsor
- Eisai Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2020-01-15
- Enrollment
- 2212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.